|Real-time Estimate - 05/13 02:24:41 pm|
Bausch Health : sells interest in Amoun Pharmaceutical for US$740 million
|03/31/2021 | 12:06pm|
Amoun is one of the largest pharmaceutical companies in
The company manufactures, markets and distributes drugs for people and animals.
The deal is expected to close in the first half of 2021, subject to customary closing conditions, including regulatory approvals.
Under the agreement, cash generated by Amoun from
This report by
Companies in this story: (TSX:BHC)
© 2021 The Canadian Press. All rights reserved., source